Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01D OTHER BETA-LACTAM ANTIBACTERIALS
J01DI Other cephalosporins and penems
J01DI01 Ceftobiprole medocaril
D08886 Ceftobiprole medocaril (USAN)
Drug groups [BR:br08330]
Antibacterial
DG01710 beta-Lactam antibiotic
DG01714 Cephalosporin skeleton group
DG01488 Cephem
DG01209 Ceftobiprole
D08886 Ceftobiprole medocaril
DG01804 Oxyimino beta-lactam
DG01209 Ceftobiprole
D08886 Ceftobiprole medocaril
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Other cephalosporin
D08886 Ceftobiprole medocaril (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08886
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08886
Drug groups [BR:br08330]
Antibacterial
DG01710 beta-Lactam antibiotic
DG01714 Cephalosporin skeleton group
DG01488 Cephem
DG01209 Ceftobiprole
DG01804 Oxyimino beta-lactam
DG01209 Ceftobiprole
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Other cephalosporin
DG01209 Ceftobiprole